ClearPoint Neuro, Inc.
US ˙ NasdaqCM ˙ US18507C1036

Introduction

This page provides a comprehensive analysis of the known insider trading history of Charles E Koob. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Charles E Koob has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:MDXG / MiMedx Group, Inc. Director 1,431,525
US:MRIC / MRI Interventions Inc Director 22,902
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Charles E Koob. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CLPT / ClearPoint Neuro, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CLPT / ClearPoint Neuro, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2015-12-18 MRIC KOOB CHARLES E 154,035 154,035 731

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CLPT / ClearPoint Neuro, Inc. Insider Trades
Insider Sales CLPT / ClearPoint Neuro, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CLPT / ClearPoint Neuro, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CLPT / ClearPoint Neuro, Inc. Insider Trades
Insider Purchases MDXG / MiMedx Group, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CLPT / ClearPoint Neuro, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2010-12-31 MDXG KOOB CHARLES E 50,486 0.9904 50,486 0.9904 50,001 14 1.42 21,689 43.38
2009-11-19 MDXG.OB KOOB CHARLES E 15,000 0.5000 15,000 0.5000 7,500
2009-10-19 MDXG.OB KOOB CHARLES E 16,668 0.4500 16,668 0.4500 7,501

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MDXG / MiMedx Group, Inc. Insider Trades
Insider Sales MDXG / MiMedx Group, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CLPT / ClearPoint Neuro, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2017-03-13 MDXG KOOB CHARLES E 50,486 8.5001 50,486 8.5001 429,136 352 7.0900 -71,190 -16.59

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MDXG / MiMedx Group, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Charles E Koob as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2020-10-05 2020-10-02 4 MDXG MIMEDX GROUP, INC.
Common Stock
A - Award 26,236 1,431,525 1.87 6.67 174,994 9,548,272
2020-09-24 2020-09-21 4 MDXG MIMEDX GROUP, INC.
Common Stock
G - Gift -50,000 1,405,289 -3.44
2020-09-24 2020-09-21 4 MDXG MIMEDX GROUP, INC.
Common Stock
G - Gift -50,000 1,405,289 -3.44
2020-08-06 2020-08-05 4 MDXG MIMEDX GROUP, INC.
Common Stock
A - Award 29,661 1,505,289 2.01
2020-01-23 2020-01-22 4 MDXG MIMEDX GROUP, INC.
Stock Option
M - Exercise -15,000 0 -100.00 1.20 -18,000
2020-01-23 2020-01-22 4 MDXG MIMEDX GROUP, INC.
Common Stock
J - Other 15,000 1,475,628 1.03
2020-01-23 2020-01-22 4 MDXG MIMEDX GROUP, INC.
Common Stock
J - Other -15,000 0 -100.00
2020-01-23 2020-01-22 4 MDXG MIMEDX GROUP, INC.
Common Stock
M - Exercise 15,000 15,000 1.20 18,000 18,000
2019-11-01 2019-07-09 4 MDXG MIMEDX GROUP, INC.
Common Stock
J - Other 723,154 1,460,628 98.06
2019-11-01 2019-07-09 4 MDXG MIMEDX GROUP, INC.
Common Stock
J - Other -723,154 0 -100.00
2019-02-08 2017-06-08 5 MDXG MIMEDX GROUP, INC.
Common Stock
J - Other 597,306 737,474 426.14
2019-02-08 2017-06-08 5 MDXG MIMEDX GROUP, INC.
Common Stock
J - Other -597,306 723,154 -45.23
2019-02-08 2017-05-01 5 MDXG MIMEDX GROUP, INC.
Common Stock
J - Other 140,168 140,168
2019-02-08 2017-05-01 5 MDXG MIMEDX GROUP, INC.
Common Stock
J - Other -140,168 1,320,460 -9.60
2018-02-06 2017-11-22 5 MDXG MIMEDX GROUP, INC.
Common Stock
G - Gift -4,000 1,460,628 -0.27
2017-10-05 2017-10-04 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 2,729 22,902 13.53 2.47 6,741 56,568
2017-05-19 2017-05-17 4 MDXG MIMEDX GROUP, INC.
Common Stock
A - Award 12,153 1,324,459 0.93
2017-05-03 2017-05-01 4 MDXG MIMEDX GROUP, INC.
Common Stock
J - Other 140,168 140,168 13.14 1,841,808 1,841,808
2017-03-15 2017-03-13 4 MDXG MIMEDX GROUP, INC.
Common Stock
S - Sale -50,486 1,312,306 -3.70 8.50 -429,136 11,154,732
2017-01-25 2016-06-06 5 MDXG MIMEDX GROUP, INC.
Common Stock
G - Gift -140,168 1,362,792 -9.33
2017-01-03 2016-12-30 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 2,749 20,173 15.78 2.64 7,257 53,257
2016-10-04 2016-09-30 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 1,014 17,424 6.18 6.65 6,743 115,870
2016-07-01 2016-06-30 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 32,491 656,429 5.21 0.21 6,823 137,850
2016-06-09 2016-06-08 4 MRIC MRI INTERVENTIONS, INC.
Stock Options (right to buy)
A - Award 20,000 20,000
2016-05-20 2016-05-18 4 MDXG MIMEDX GROUP, INC.
Common Stock
A - Award 21,429 1,502,960 1.45
2016-04-01 2016-03-31 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 21,945 623,938 3.65 0.31 6,803 193,421
2016-01-04 2015-12-31 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 19,097 601,993 3.28 0.38 7,257 228,757
2015-12-21 2015-12-18 4 MRIC MRI INTERVENTIONS, INC.
Series B Warrants (right to buy)
P - Purchase 46,211 46,211
2015-12-21 2015-12-18 4 MRIC MRI INTERVENTIONS, INC.
Series A Warrants (right to buy)
P - Purchase 61,614 61,614
2015-12-21 2015-12-18 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
P - Purchase 154,035 736,931 26.43
2015-10-02 2015-10-01 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 11,252 582,896 1.97 0.60 6,751 349,738
2015-07-02 2015-06-30 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 6,266 571,644 1.11 1.08 6,767 617,376
2015-06-09 2015-06-05 4 MRIC MRI INTERVENTIONS, INC.
Stock Options (right to buy)
A - Award 20,000 20,000
2015-05-18 2015-05-14 4 MDXG MIMEDX GROUP, INC.
Common Stock
A - Award 12,878 1,481,531 0.88
2015-04-02 2015-03-31 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 7,250 565,378 1.30 1.00 7,250 565,378
2015-01-05 2014-12-31 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 8,410 558,128 1.53 0.86 7,249 481,106
2014-10-02 2014-09-30 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 5,894 549,718 1.08 1.23 7,250 676,153
2014-07-30 2014-07-28 4 MDXG MIMEDX GROUP, INC.
Stock Option
A - Award 15,000 15,000
2014-07-30 2014-07-28 4 MDXG MIMEDX GROUP, INC.
Common Stock
A - Award 9,000 1,468,653 0.62
2014-07-30 2013-06-05 4 MDXG MIMEDX GROUP, INC.
Warrant
M - Exercise -50,000 0 -100.00
2014-07-30 2013-06-05 4 MDXG MIMEDX GROUP, INC.
Common Stock
M - Exercise 50,000 1,459,653 3.55 1.00 50,000 1,459,653
2014-07-02 2014-06-30 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 7,107 543,824 1.32 1.02 7,249 554,700
2014-06-05 2014-06-04 4 MRIC MRI INTERVENTIONS, INC.
Stock Options (right to buy)
A - Award 20,000 20,000
2014-04-02 2014-03-31 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 6,142 536,717 1.16 1.24 7,616 665,529
2014-01-03 2013-12-31 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 5,263 530,575 1.00 1.33 7,000 705,665
2013-10-01 2013-09-30 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 4,609 525,312 0.89 1.41 6,499 740,690
2013-07-01 2013-06-28 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 11,818 520,703 2.32 1.10 13,000 572,773
2013-06-26 2013-06-14 4 MRIC MRI INTERVENTIONS, INC.
Stock Options (right to buy)
A - Award 20,000 20,000
2013-05-13 2013-05-09 4 MDXG MIMEDX GROUP, INC.
Stock Option
A - Award 15,000 60,000 33.33 6.60 99,000 396,000
2013-05-13 2013-05-09 4 MDXG MIMEDX GROUP, INC.
Restricted Common Stock
A - Award 5,000 1,409,653 0.36 6.60 33,000 9,303,710
2012-11-05 2012-10-31 4/A MDXG MIMEDX GROUP, INC.
Stock Option
A - Award 15,000 45,000 50.00 2.94 44,100 132,300
2012-11-02 2012-10-31 4 MDXG MIMEDX GROUP, INC.
Stock Option
A - Award 15,000 65,000 30.00 2.94 44,100 191,100
2012-10-19 2012-10-17 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
A - Award 8,594 508,885 1.72 2.40 20,626 1,221,324
2012-09-05 2012-09-04 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
G - Gift -50,000 500,291 -9.09
2012-08-17 2012-08-17 4 MRIC MRI INTERVENTIONS, INC.
Warrants (right to buy)
X - Other -50,000 0 -100.00
2012-08-17 2012-08-17 4 MRIC MRI INTERVENTIONS, INC.
Common Stock
X - Other 50,000 550,291 9.99 0.01 500 5,503
2012-07-30 2012-07-27 4 MDXG MIMEDX GROUP, INC.
Warrant
X - Other -25,243 50,000 -33.55 1.50 -37,864 75,000
2012-07-30 2012-07-27 4 MDXG MIMEDX GROUP, INC.
Common Stock
X - Other 25,243 1,404,653 1.83 1.50 37,864 2,106,980
2012-04-17 2012-04-13 4 NONE MRI INTERVENTIONS, INC.
Stock Option (right to buy)
A - Award 45,000 45,000
2012-03-29 2012-03-27 4 MDXG MIMEDX GROUP, INC.
Warrant
X - Other -12,622 75,243 -14.37 0.01 -126 752
2012-03-29 2012-03-27 4 MDXG MIMEDX GROUP, INC.
Common Stock
X - Other 12,622 1,379,410 0.92 0.01 126 13,794
2012-03-09 2012-03-09 4 MDXG MIMEDX GROUP, INC.
Warrant
A - Award 12,622 87,865 16.77 0.01 126 879
2012-02-27 3 NONE MRI INTERVENTIONS, INC.
Common Stock
20,000
2012-02-27 3 NONE MRI INTERVENTIONS, INC.
Common Stock
480,291
2012-02-15 2012-02-14 4 MDXG MIMEDX GROUP, INC.
Stock Option
X - Other 100,000 30,000 -142.86 1.00 100,000 30,000
2012-02-15 2012-02-14 4 MDXG MIMEDX GROUP, INC.
Common Stock
X - Other 100,000 1,366,788 7.89 1.00 100,000 1,366,788
2012-02-01 2012-01-31 4 MDXG MIMEDX GROUP, INC.
Common Stock
A - Award 38,813 1,266,788 3.16 1.10 42,694 1,393,467
2011-12-16 2011-12-14 4 MDXG MIMEDX GROUP, INC.
Stock Option
A - Award 15,000 130,000 13.04 1.10 16,500 143,000
2011-01-04 2010-12-31 4 MDXG MIMEDX GROUP, INC.
Warrant
P - Purchase 25,243 190,243 15.30 1.50 37,864 285,364
2011-01-04 2010-12-31 4 MDXG MIMEDX GROUP, INC.
Common Stock
P - Purchase 50,486 1,227,975 4.29 0.99 50,001 1,216,186
2011-01-04 2010-10-20 4 MDXG MIMEDX GROUP, INC.
Warrant
P - Purchase 50,000 165,000 43.48 1.00 50,000 165,000
2010-05-14 2010-05-11 4 MDXG.OB MIMEDX GROUP, INC.
Stock Option
A - Award 15,000 15,000
2010-05-04 2010-03-31 4 MDXG.OB MIMEDX GROUP, INC.
3% Convertible Senior Secured Promissory Note
C - Conversion -300,000 0 -100.00 150,000.00 -45,000,000,000
2010-05-04 2010-03-31 4 MDXG.OB MIMEDX GROUP, INC.
3% Convertible Senior Secured Promissory Note
A - Award 308,821 308,821 0.50 154,410 154,410
2009-11-20 2009-11-19 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock
P - Purchase 15,000 868,668 1.76 0.50 7,500 434,334
2009-10-21 2009-10-19 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock
P - Purchase 16,668 853,668 1.99 0.45 7,501 384,151
2009-08-21 2009-08-20 4 MDXG.OB MIMEDX GROUP, INC.
Common Stock
A - Award 37,000 837,000 4.62
2008-02-15 3 AYXC.OB Alynx, Co.
Series A Preferred Stock
120,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)